The use of four-factor prothrombin complex concentrate in patients with liver disease on warfarin therapy

被引：2
|
作者：
Stevens, Craig A. [1 ]
Yau, Benny C. [2 ]
Lai, Ngan C. [3 ]
Huang, Wan-Ting [1 ]
Cang, William C. [1 ]
Bushway, Audrey [1 ]
Derry, Katrina L. [1 ]
机构：
[1] UC San Diego Hlth, Dept Pharm, San Diego, CA USA
[2] Stanford Hlth Care, Dept Pharm, Stanford, CA USA
[3] Sutter Hlth Care, Dept Pharm, Oakland, CA USA
来源：
THROMBOSIS RESEARCH | 2021年 / 204卷
关键词：
COAGULOPATHY; PROTECT;
D O I：
10.1016/j.thromres.2021.06.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 50 条
  • [41] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for Warfarin Reversal-A Critical Appraisal of the Evidence
    Jones, G. Morgan
    Davidson, K. Erin
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (03) : E375 - E377
  • [42] EVALUATION OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR BLEEDING IN CARDIAC SURGERY
    Helfenbein, Kylie
    Desai, Payal
    Pavlik, Nicole
    Sethi, Samir
    Larosa, Jennifer
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [43] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Denise H. Rhoney
    Mary La
    Molly Merz
    Aaron Cook
    Kent A. Owusu
    Christina Roels
    Joe Blunck
    Justin Shewmaker
    Kiranpal S. Sangha
    Salia Farrokh
    John Lewin
    Kathleen W. Chester
    Theresea Human
    Kathleen Bledsoe
    Kristy Greene
    Melissa Levesque
    Jody C. Rocker
    Gary Davis
    Ron Neyens
    Timothy F. Lassiter
    Sarah M. Adriance
    Neurocritical Care, 2021, 35 : 130 - 138
  • [44] Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
    Rech, Megan A.
    Masic, Dalila
    Hammond, Drayton A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (02) : 163 - 169
  • [45] STABILITY OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE AFTER PNEUMATIC TUBING
    Jun, Ah Hyun
    Chester, Katleen
    Winkler, Anne
    Webb, Adam
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [46] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR THE REVERSAL OF DIRECT ORAL ANTICOAGULANTS
    Zada, Ilanit
    Wang, Shan
    Akerman, Meredith
    Hanna, Adel
    CRITICAL CARE MEDICINE, 2020, 48
  • [47] Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding
    Tanaka, Kenichi A.
    Shettar, Shashank
    Vandyck, Kofi
    Shea, Susan M.
    Abuelkasem, Ezeldeen
    TRANSFUSION MEDICINE REVIEWS, 2021, 35 (04) : 96 - 103
  • [48] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Rhoney, Denise H.
    La, Mary
    Merz, Molly
    Cook, Aaron
    Owusu, Kent A.
    Roels, Christina
    Blunck, Joe
    Shewmaker, Justin
    Sangha, Kiranpal S.
    Farrokh, Salia
    Lewin, John
    Chester, Kathleen W.
    Human, Theresea
    Bledsoe, Kathleen
    Greene, Kristy
    Levesque, Melissa
    Rocker, Jody C.
    Davis, Gary
    Neyens, Ron
    Lassiter, Timothy F.
    Adriance, Sarah M.
    NEUROCRITICAL CARE, 2021, 35 (01) : 130 - 138
  • [49] Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population
    Sandquist, Katherine
    Kaucher, Kevin
    Newell, Joshua
    Sarangarm, Preeyaporn
    Burnett, Allison
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (03) : 124 - 128
  • [50] Evaluation of fixed dose four-factor prothrombin complex concentrate for warfarin reversal at a level 1 trauma center
    H Drone
    J Jancik
    J Gorlin
    M McCarthy
    Critical Care, 19 (Suppl 1):
12345